AbbVie and AstraZeneca settle cancer drug patent suits

25-10-2019

Sarah Morgan

AbbVie and AstraZeneca settle cancer drug patent suits

Piotr Swat / Shutterstock.com

AbbVie and AstraZeneca reached a settlement over patent suits involving their rival cancer drugs earlier this week, after nearly two years of litigation.


AbbVie, AstraZeneca, cancer drugs, litigation, settlement, Pharmacyclics, Acerta, FDA, Calaquence, Imbruvica

LSIPR